Treating head and neck cancer with selective neck dissection showed an improvement in shoulder function when level 2b neck dissection was omitted in treatment, according to a recent study.
A recent study suggested the activation of apelin/APJ signaling decreased efficacy in VEGF treatment, while bevacizumab decreased disease-free survival rates with increased expression of apelin in patients of ovarian cancer.
Idelalisib May Induce More Favorable Outcomes in Clinical Trial Participants, Versus Medicare Beneficiaries
Medicare beneficiaries saw unfavorable results when compared to clinical trial participants being treated with idelalisib for their follicular lymphoma or chronic lymphocytic leukemia.
A recent study shows the importance of information regarding adverse events of cancer treatment for prospective patients.
A study showed that first-line treatment for epithelial ovarian cancer using weekly dose-dense chemotherapy did not improve progression-free survival, compared with 3-weekly chemotherapy, in European women.
Lawrence Feldman, MD, of the division of hematology and oncology in the department of medicine at the University of Illinois at Chicago, and a team of researchers received a grant to explore addiction, abuse, and new ways to prescribe opioids.
Seattle Genetics announced the development after data was presented at the 2019 San Antonio Breast Cancer Symposium.
Screening colonoscopy rates for colorectal cancer increased in low-income Latino populations when accompanied by patient navigation.